Nordic Life Science Days in Stockholm, 9-10 of September 2015, set a new record for attendance and offered a lot of interesting business opportunities.
Investors and companies have just finished two days of business meetings, dialogs and new life science opportunities at the Nordic Life Science Days, held at Stockholm Waterfront. The annual conference offered panel discussions, exhibitions, company presentations and face-to-face meetings. Among the investors and large firms that attended the conference this year was AstraZeneca, Boehringer Ingelheim, Johnson & Johnson, Pfizer, Novartis, Recipharm, Roche and AbbVie, to name just a few.
The event also offered a range of conference sessions. Development trends and strategies for orphan drugs, personalized healthcare, the Baltic Sea region and the financial climate in the current life science climate were some of the topics that was discussed during the conference. The 2015 conference design also had a new exhibition layout to create more interactions with the exhibitors, ten super sessions and new partnering areas.
New record of attendance
This year’s event also set a new record for attendance, with over 1000 delegates from 31 countries.
“NLSDays has continued to grow and established a strong reputation. We are particularly pleased to see the high level of international interest, which is a recognition of the thriving entrepreneurial life science environment here and we look forward to continuing to develop and expand NLSDays over the coming years,” stated Jonas Ekstrand, Director General SwedenBIO.
Life Science agreement between Sweden and Lithuania
Yesterday, Enterprise Lithuania and the Swedish LIfe Science Industry Organization, SwedenBIO (and host of the Conference) announced the signing of a Memorandum of Understanding (MoU) to facilitate collaboration between both the organizations and the countries’ Life science research centres and industries.
“We have always admired Sweden and hope this MoU will lead to joint investment, cooperation and innovative projects, based around our key strengths in areas such as laser and medical device technology, biologics, informatics and clinical trials,” said Mr. Mantas Nocius, Managing Director of Enterprise Lithuania.
Nordic Star 2015 Award
Today, the winners of the Nordic Star 2015 Award was also announced and this year’s recipients were AMRA, Bergenbio and Nextstim. The Award was introduced in 2013 in special recognition of Life science companies in the Nordic region demonstrating outstanding innovation and entrepreneurial skills.
“This year’s Winners are clearly future-oriented and committed to working in new ways to bring Medical innovations to patients. They are both role models for others and an example of the innovation capacity in the Life sciences in the Nordic countries,” said Jonas Ekstrand.
The new Value Chain and the Future
This year’s theme of the conference was “The New Value Chain and the Future” and the focus lied on three trends: Digitalization, Precision and Preventive Medicine and Breakthrough Therapies.
Photographer: Mikael Wallerstedt